Publications by authors named "Rocio Aller"

Claim this Profile
C
Circulating Extracellular Vesicle miR-150-5p as a biomarker for optimizing clinical management of sepsis and septic shock: A discovery and validation Study.
Marta Martín-Fernández, Belén Sánchez-Quirós, Adrián García-Concejo, Álvaro Tamayo-Velasco, Rocío López-Herrero, Rocío Aller

J Infect Public Health· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.
Stephania C Isaza, Carlos Ernesto Fernández-García, Diego Rojo, Paula Iruzubieta, Javier Ampuero, Rocío Aller

Biomark Res· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multidisciplinary clinical practice guideline on the management of metabolic hepatic steatosis.
Manuel Romero-Gómez, Javier Escalada, Mar Noguerol, Antonio Pérez, Juana Carretero, Rocío Aller

Gastroenterol Hepatol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic dysfunction-associated Steatotic Liver Disease in Clinical Practice.
Antonio Olveira, Javier Crespo, Luis Ibañez-Samaniego, Rocío Gallego-Durán, Jose Luis Calleja, Rocío Aller

Clin Gastroenterol Hepatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of Candidates for MASLD Treatment With Indeterminate Vibration-Controlled Transient Elastography.
David Marti-Aguado, José Miguel Carot-Sierra, Aida Villalba-Ortiz, Harris Siddiqi, Rose Marie Vallejo-Vigo, Rocío Aller

Clin Gastroenterol Hepatol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Letter to the Editor: Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Mazen Noureddin, Emily Truong, Rebeca Mayo, Ibon Martínez-Arranz, Itziar Mincholé, Rocio Aller

Hepatology· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH).
Edilmar Alvarado-Tapias, Douglas Maya-Miles, Agustin Albillos, Rocio Aller, Javier Ampuero

Gastroenterol Hepatol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fibroblast growth factor 21 is a hepatokine involved in MASLD progression.
Rocío Gallego-Durán, Javier Ampuero, Douglas Maya-Miles, Helena Pastor-Ramírez, Rocío Montero-Vallejo, Rocío Aller

United European Gastroenterol J· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
One-step non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis and fibrosis in high-risk population.
Paula Iruzubieta, Rebeca Mayo, Itziar Mincholé, Ibon Martínez-Arranz, María Teresa Arias-Loste, Rocío Aller

United European Gastroenterol J· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Javier Ampuero, Rocío Aller, Rocío Gallego-Durán, Javier Crespo, Jose Luis Calleja, Joan Caballería

J Gastroenterol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced fibrosis associated with non-alcoholic steatohepatitis (NASH) in Spain: results of a Delphi study.
Rocío Aller, José Luis Calleja, Javier Crespo, Manuel Romero-Gómez, Juan Turnes

Gastroenterol Hepatol· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Angelo Armandi, Tiziana Sanavia, Ramy Younes, Gian Paolo Caviglia, Chiara Rosso, Rocio Aller

Gut· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Serum identification of at-risk MASH: The metabolomics-advanced steatohepatitis fibrosis score (MASEF).
Mazen Noureddin, Emily Truong, Rebeca Mayo, Ibon Martínez-Arranz, Itziar Mincholé, Rocio Aller

Hepatology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocol.
Michael Pavlides, Ferenc E Mózes, Salma Akhtar, Kristy Wonders, Jeremy Cobbold, Rocio Aller

Contemp Clin Trials· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of EpCAM+ CD133+ extracellular vesicles in steatosis to steatohepatitis transition in NAFLD.
Rocío Muñoz-Hernández, Sheila Gato, Antonio Gil-Gómez, Rocío Aller, Angela Rojas

Liver Int· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship of resistin gene polymorphism (rs7139228) with resistin levels and metabolic syndrome risk in obese subjects.
Daniel de Luis Román, Katia Benito-Sendín Plaar, David Primo Martín, Olatz Izaola, Rocío Aller

Nutr Hosp· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AEEH «Consensus about detection and referral of hidden prevalent liver diseases».
Manuel Romero-Gómez, Rocío Aller, Javier Ampuero, Conrado Fernández Rodríguez, Salvador Augustín

Gastroenterol Hepatol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the leptin receptor rs 1805134 polymorphism with obesity parameters, dietary intakes, and metabolic syndrome in Caucasian obese subjects.
Rocío Aller, David Primo Martín, Olatz Izaola, José Alfredo Martínez, Daniel de Luis Román

Nutr Hosp· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary intervention with 2 different fat profiles; role of the rs822393 variant in metabolic parameter changes.
Rocío Aller, Olatz Izaola, David Primo Martín, José Alfredo Martínez, Daniel de Luis Román

Nutr Hosp· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of resistin (rs7139228) gene polymorphism with metabolic response after a hypocaloric mediterranean diet.
Daniel Antonio de Luis, David Primo, Olatz Izaola, Rocío Aller

Endocrinol Diabetes Nutr (Engl Ed)· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective.
Manuel Romero-Gómez, Rocío Aller, Franz Martín-Bermudo

Semin Liver Dis· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of Oxidative Stress and Lipid Peroxidation in the Pathophysiology of NAFLD.
Marta Martín-Fernández, Víctor Arroyo, Carmen Carnicero, Rebeca Sigüenza, Reyes Busta, Rocío Aller

Antioxidants (Basel)· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence estimation of significant fibrosis because of NASH in Spain combining transient elastography and histology.
José L Calleja, Jesús Rivera-Esteban, Rocío Aller, Marta Hernández-Conde, Javier Abad

Liver Int· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of the APOA-5 Genetic Variant rs662799 with Metabolic Changes after an Intervention for 9 Months with a Low-Calorie Diet with a Mediterranean Profile.
Daniel de Luis Roman, David Primo, Olatz Izaola, Rocio Aller

Nutrients· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Trial with Two Hypocaloric Diets with Different Lipid Profiles and Effects on Serum Omentin-1 Levels in Obese Subjects.
Daniel de Luis, Olatz Izaola, David Primo, Rocio Aller

Dis Markers· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis